Trials that use: Exact / Clopper-Pearson binomial
New to this method? Read the tutorial →
800 results
- A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer.: Complete Statistical AnalysisIndependent statistical analysis of A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF): Complete Statistical AnalysisIndependent statistical analysis of A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF): primary endpoint results, effect estimate with confidence interval,…
- A Study of BAX 888 in Male Adults With Severe Hemophilia A: Complete Statistical AnalysisIndependent statistical analysis of A Study of BAX 888 in Male Adults With Severe Hemophilia A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies: Complete Statistical AnalysisIndependent statistical analysis of A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Study of Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic Melanoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of BGB324 (Bemcentinib) in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of BGB324 (Bemcentinib) in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001): Complete Statistical AnalysisIndependent statistical analysis of A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Study of Capmatinib (INC280) in NSCLC Patients With MET Exon 14 Alterations Who Have Received Prior MET Inhibitor: Complete Statistical AnalysisIndependent statistical analysis of A Study of Capmatinib (INC280) in NSCLC Patients With MET Exon 14 Alterations Who Have Received Prior MET Inhibitor: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074): Complete Statistical AnalysisIndependent statistical analysis of A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of CS1001 in Subjects With Relapsed or Refractory Extranodal Natural Killer/ T Cell Lymphoma(ENKTL): Complete Statistical AnalysisIndependent statistical analysis of A Study of CS1001 in Subjects With Relapsed or Refractory Extranodal Natural Killer/ T Cell Lymphoma(ENKTL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection: Complete Statistical AnalysisIndependent statistical analysis of A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Study of Darvadstrocel for Treating Complex Perianal Fistulas in Children and Teenagers With Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study of Darvadstrocel for Treating Complex Perianal Fistulas in Children and Teenagers With Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of DS-7011a in Patients With Systemic Lupus Erythematosus: Complete Statistical AnalysisIndependent statistical analysis of A Study of DS-7011a in Patients With Systemic Lupus Erythematosus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05638802).
- A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy: Complete Statistical AnalysisIndependent statistical analysis of A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy: primary endpoint results, effect estimate with confidence interval,…
- A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations: Complete Statistical AnalysisIndependent statistical analysis of A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of Efficacy and Safety of LAG525 in Combination With Spartalizumab, or With Spartalizumab and Carboplatin, or With Carboplatin, in Patients With Advanced Triple-negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Efficacy and Safety of LAG525 in Combination With Spartalizumab, or With Spartalizumab and Carboplatin, or With Carboplatin, in Patients With Advanced Triple-negative Breast Cancer: primary…
- A Study of EMD525797 in Solid Tumor Patients in Japan: Complete Statistical AnalysisIndependent statistical analysis of A Study of EMD525797 in Solid Tumor Patients in Japan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01327313).
- A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) Infection: Complete Statistical AnalysisIndependent statistical analysis of A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203): Complete Statistical AnalysisIndependent statistical analysis of A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors: Complete Statistical AnalysisIndependent statistical analysis of A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Galcanezumab in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of Galcanezumab in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02576951).
- A Study of Galunisertib in Participants With Myelodysplastic Syndromes: Complete Statistical AnalysisIndependent statistical analysis of A Study of Galunisertib in Participants With Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02008318).
- A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM): Complete Statistical AnalysisIndependent statistical analysis of A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Study of HMPL-306 in Advanced Hematological Malignancies With mIDH: Complete Statistical AnalysisIndependent statistical analysis of A Study of HMPL-306 in Advanced Hematological Malignancies With mIDH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04764474).
- A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202): Complete Statistical AnalysisIndependent statistical analysis of A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M Mutations: Complete Statistical AnalysisIndependent statistical analysis of A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M Mutations: primary endpoint…
- A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion: Complete Statistical AnalysisIndependent statistical analysis of A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of Intravenous Mircera in Dialysis Patients With Chronic Renal Disease and Anemia.: Complete Statistical AnalysisIndependent statistical analysis of A Study of Intravenous Mircera in Dialysis Patients With Chronic Renal Disease and Anemia.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Intravenous Perampanel in Japanese Participants With Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of A Study of Intravenous Perampanel in Japanese Participants With Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03754582).
- A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease: primary endpoint results, effect estimate with confidence…
- A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B): Complete Statistical AnalysisIndependent statistical analysis of A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors: Complete Statistical AnalysisIndependent statistical analysis of A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy: Complete Statistical AnalysisIndependent statistical analysis of A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy: primary endpoint results, effect estimate with confidence…
- A Study of LY2541546 in Healthy Postmenopausal Women: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY2541546 in Healthy Postmenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01742078).
- A Study of LY2928057 in Hemodialysis Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY2928057 in Hemodialysis Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01991483).
- A Study of LY2940680 in Japanese Participants With Advanced Cancers: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY2940680 in Japanese Participants With Advanced Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01919398).
- A Study of LY2944876 in Healthy Japanese and Non-Japanese Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY2944876 in Healthy Japanese and Non-Japanese Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02188303).
- A Study of LY3039478 in Participants With Advanced Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY3039478 in Participants With Advanced Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01695005).
- A Study of LY3053102 in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY3053102 in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01736241).
- A Study of LY3113593 in Participants With Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY3113593 in Participants With Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02604160).
- A Study of LY3526318 in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY3526318 in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03977974).
- A Study of MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin’s Lymphoma (NHL): Complete Statistical AnalysisIndependent statistical analysis of A Study of MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin's Lymphoma (NHL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of MK-2060 in Participants With Chronic and/or End-Stage Kidney Disease (MK-2060-011): Complete Statistical AnalysisIndependent statistical analysis of A Study of MK-2060 in Participants With Chronic and/or End-Stage Kidney Disease (MK-2060-011): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…